Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Duloxetine hydrochloride
Drug ID BADD_D00735
Description Duloxetine is a dual serotonin and norepinephrine reuptake inhibitor.[label] It was originally discovered in 1993 and developed by Eli Lilly and Company as LY248686.[A178741] Duloxetine first received approval from the FDA in August, 2004 as Cymbalta for the treatment of Major Depressive Disorder.[L6454] It has since received approval for a variety of indications including the treatment of neuropathic pain, Generalized Anxiety disorder, osteoarthritis, and stress incontinence. Duloxetine continues to be investigated for the treatment of pain in cancer, surgery, and more.
Indications and Usage Authors unspecified: Duloxetine: new indication. Depression and diabetic neuropathy: too many adverse effects. Prescrire Int. 2006 Oct;15(85):168-72.
Marketing Status Prescription
ATC Code N06AX21
DrugBank ID DB00476
KEGG ID D01179
MeSH ID D000068736
PubChem ID 60834
TTD Drug ID D01AXB
NDC Product Code 33342-161; 59651-282; 50771-203; 51991-747; 59286-1046; 73476-747; 51991-750; 55154-2341; 62128-0386; 71335-0509; 50436-0748; 0110-3235; 17337-0017; 60429-164; 55289-028; 50090-3205; 0904-6454; 43353-960; 0904-7045; 33342-162; 0110-9542; 65015-713; 0110-3240; 51927-0059; 51991-746; 17337-0046; 61919-482; 63629-1991; 68788-7897; 0002-3235; 51991-748; 71610-218; 63629-2063; 68788-9301; 45865-815; 70934-729; 73476-746; 68071-5104; 68001-414; 60429-165; 59651-280; 59651-279; 68001-413; 0904-7044; 0110-9543; 55154-7889; 50771-201; 55154-7878; 43063-877; 0904-6453; 49587-111; 50771-202; 43063-878; 63187-720; 61919-042; 71335-0392; 63187-735; 43353-106; 50436-0747; 55111-859; 73476-748; 63187-702; 14501-0005; 50090-2226; 63187-716; 43353-025; 55154-2342; 73476-750; 33342-160; 0904-7043; 63187-172; 60505-2995; 55289-036; 68788-7619; 63187-666; 71610-402; 0002-3240; 65862-463; 63187-181; 51927-4999; 0110-3270; 50090-2844; 71610-401; 63629-1990; 70518-0343; 71335-0165; 55745-0004; 0110-9544; 57237-018; 70518-1802; 68001-368; 0395-8106; 50090-2585; 0002-3270; 63629-1992; 57237-019; 71554-015; 0110-9545; 68108-0705; 68001-415; 16436-0077; 57237-017; 60505-2996; 60429-166; 63187-612; 60505-2997
Synonyms Duloxetine Hydrochloride | Hydrochloride, Duloxetine | Duloxetine HCl | HCl, Duloxetine | LY 248686 | LY-248686 | LY248686 | Duloxetine Ethanedioate (1:1), (+-)-isomer - T353987 | LY 227942 | LY-227942 | LY227942 | Duloxetine | N-methyl-3-(1-naphthalenyloxy)-3-(2-thiophene)propanamide | N-methyl-3-(1-naphthalenyloxy)-2-thiophenepropanamine | Duloxetine, (+)-isomer | Cymbalta
Chemical Information
Molecular Formula C18H20ClNOS
CAS Registry Number 136434-34-9
SMILES CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32.Cl
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal discomfort07.01.06.001--Not Available
Abdominal pain07.01.05.002--
Abdominal pain lower07.01.05.010--Not Available
Abdominal pain upper07.01.05.003--
Abdominal tenderness07.01.05.004--Not Available
Abnormal dreams19.02.03.001; 17.15.02.001--Not Available
Aggression19.05.01.001--Not Available
Agitation19.06.02.001; 17.02.05.012--
Akathisia19.06.02.006; 17.01.02.002--
Alanine aminotransferase13.03.01.031--Not Available
Alanine aminotransferase increased13.03.01.003--
Alopecia23.02.02.001--
Anaemia01.03.02.001--
Anaphylactic reaction24.06.03.006; 10.01.07.001--
Anaphylactic shock24.06.02.004; 10.01.07.002--Not Available
Anger19.04.02.001--Not Available
Angioedema23.04.01.001; 10.01.05.009--Not Available
Angle closure glaucoma06.03.01.001--Not Available
Anorgasmia19.08.01.001--
Anxiety19.06.02.002--
Apathy19.04.04.002--Not Available
Aphthous ulcer07.05.06.002--Not Available
Arrhythmia02.03.02.001--Not Available
Arrhythmia supraventricular02.03.03.001--Not Available
Arthralgia15.01.02.001--
Aspartate aminotransferase13.03.01.032--Not Available
Aspartate aminotransferase increased13.03.01.006--
Asthenia08.01.01.001--Not Available
Ataxia17.02.02.001; 08.01.02.004--
Atrial fibrillation02.03.03.002--
The 1th Page    1 2 3 4 5    Next   Last    Total 11 Pages